Join the Diarrhea, Acute group to help and get support from people like you.
Diarrhea, Acute News
Related terms: Diarrhea, drug-induced
Increases in Incidence of Certain Foodborne Diseases Seen During 2023
MONDAY, July 8, 2024 – During 2023, there were increases in the incidences of certain foodborne disease, which may reflect changes in diagnostic practices, according to research published in the...
Cucumbers Sold in 14 States Recalled Over Salmonella Concerns
TUESDAY, June 4, 2024 – A company recall has been issued for cucumbers sold in 14 states because of possible contamination with salmonella. In a notice posted by the U.S. Food and Drug...
E. Coli Outbreak Tied to Raw Milk Cheese
MONDAY, Feb. 19, 2024 – Raw milk cheese tainted with E. coli bacteria has sickened 10 people in four states, hospitalizing four, federal regulators warn. The cases have been tied to Raw Farm brand...
CDC Investigating Illness Outbreak on Luxury Cruise Ship
Thursday, Feb. 8, 2024 – The U.S. Centers of Disease Control and Prevention is investigating an outbreak of gastrointestinal illness aboard a luxury cruise ship that sailed out of San Francisco on...
Climate Change Could Make Diarrheal Illness More Common
FRIDAY, Jan. 19, 2024 – People are more prone to coming down with a common gastrointestinal infection on hot, humid days, new research shows. The British study suggests that climate change and...
FDA Medwatch Alert: Drug Safety Communication: Imodium (loperamide) for Over-the-Counter Use - FDA Limits Packaging To Encourage Safe Use
ISSUE: To foster safe use of the over-the counter (OTC) anti-diarrhea drug loperamide, FDA is working with manufacturers to use blister packs or other single dose packaging and to limit the number of...
FDA Medwatch Alert: Diphenoxylate Hydrochloride and Atropine Sulfate Tablets by Greenstone: Recall - Possible Sub Potent and Super Potent Tablets
ISSUE: Greenstone, a wholly owned subsidiary of Pfizer Inc., is voluntarily recalling multiple lots of diphenoxylate hydrochloride and atropine sulfate tablets, USP to the consumer level. Greenstone...
FDA Approves Fulyzaq - First Anti-Diarrheal Drug for HIV/AIDS Patients
December 31, 2012 – The U.S. Food and Drug Administration today approved Fulyzaq (crofelemer) to relieve symptoms of diarrhea in HIV/AIDS patients taking antiretroviral therapy, a combination of...
Ask a question
To post your own question to this support group, sign in or create an account.